Related Experiment Videos
Association between dopamine receptor D1 A-48G polymorphism and methamphetamine abuse
Hsing-Cheng Liu1, Chih-Ken Chen, Sy-Jye Leu
1Department of Psychiatry, Taipei City Hospital, Taiwan.
Psychiatry and Clinical Neurosciences
|April 6, 2006
Summary
This study found no link between the DRD1 A-48G gene variant and methamphetamine abuse or psychosis. Male sex and frequent methamphetamine use were identified as risk factors for developing methamphetamine-induced psychosis.
Area of Science:
- Neuroscience
- Genetics
- Psychiatry
Background:
- Substance abuse is linked to the brain's dopamine reward system.
- Dopamine receptor D1 (DRD1) activity is crucial in this system.
Purpose of the Study:
- To investigate the association between the DRD1 A-48G polymorphism and methamphetamine (MAP) abuse.
- To examine the relationship between this polymorphism and MAP-induced psychosis.
Main Methods:
- Genotyping of the DRD1 A-48G polymorphism using polymerase chain reaction-restriction fragment length polymorphism.
- Clinical evaluation of 363 MAP abusers and 425 healthy controls using the Structural Diagnostic Interview for Genetic Study.
- Classification of MAP abusers into psychosis (n=135) and non-psychosis (n=228) groups.
Main Results:
- Male sex and higher MAP abuse frequency were identified as predisposing factors for MAP-induced psychosis.
- DRD1 -48G allele frequencies were 0.14 (psychosis), 0.18 (non-psychosis), and 0.16 (controls).
- No significant association was found between DRD1 A-48G polymorphism and MAP abuse or psychosis.
Conclusions:
- The DRD1 A-48G polymorphism is not directly associated with methamphetamine abuse or psychosis.
- Findings suggest potential ethnicity-related differences in polymorphism distribution compared to prior research.
- Male gender and increased MAP use frequency are risk factors for psychosis in MAP abusers.